AboutContact us
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
From Iron Dome to Arrow missiles, unpaid bills accumulate in Israel’s defense sector
2
The 50 most promising Israeli startups - 2026
3
Indian Embassy cancels $42 million Tel Aviv office deal at last minute
4
Crypto unicorn MoonPay acquires Israeli security startup Sodot for $100 million
5
The iron gateway to Europe: The connection between German engineering and Israeli audacity
More news

Biotech

20 stories about Biotech
ארליך – קולינג קרופס

Israeli startup aims to cool the planet through agriculture

19.04.26|Hagay Gilboa, Maor Shalom Swisa
New technology developed by Cooling Crops lowers crop temperatures and restores degraded soil.
Scala foudners

Scala Biodesign raises $16 million Series A to accelerate AI-driven drug development

31.03.26|Meir Orbach
The Israeli startup aims to cut years from protein engineering timelines.
צוות העובדים של Starget Pharma

Israeli biotech Starget secures $18 million Series A to accelerate precision cancer treatments

18.02.26|Meir Orbach
The Israeli startup is set to launch advanced trials for first-of-its-kind sarcoma treatment in collaboration with MD Anderson. 
Converge Bio מפתחת פלטפורמת בינה מלאכותית לגילוי ופיתוח תרופות

Converge Bio raises $25 million Series A to accelerate AI drug discovery

13.01.26|CTech
The funding brings total investment to $30 million as the startup works with pharma partners on antibody design and protein optimization. 
Pini Orbach

Arkin raises $100 million biotech fund focused on early clinical science

12.01.26|CTech
Arkin Bio Ventures III emphasizes scientific rigor amid shifting biotech markets.
וירוס וירוסים חיידק חיידקים בקטריות

BiomX collapses into court proceedings after clinical trial fails

17.12.25|Lital Dobrovitzky
Israeli biotech seeks trustee to manage asset sales amid NIS 11 million debt.
CTech Berlin Conference - Dr. Lior Shaltiel

“To get Israel to a more precise position in biotech, we need to educate our people to become better managers”

07.12.25|Zachy Hennessey
Dr. Lior Shaltiel, CEO of NurExone Biologic, speaks to CTech at Calcalist, CTech and Bank Leumi’s Mind The Tech conference in Berlin.  
לייפנפלד )מימין( וכהן־סולל במשרדי NeuroKairs בתל אביב. "יכולנו לשבת כמו כל הסטארט־ אפים באחד ממגדלי ההייטק, אבל חשוב לנו לא להוציא כסף על מה שלא חובה"

The women turning a blood sample into a map of the depressed brain

27.11.25|Sophie Shulman
Tel Aviv-based NeuroKaire is using “brain-in-a-dish” models to personalize antidepressants, and is now shifting from years of research to full-scale commercialization in Israel and the U.S.
Cassidy Bio founders

Cassidy Bio raises $8M Seed round to build AI-first platform for designing genetic medicines

20.11.25|CTech
Founders include CRISPR, AI, and biotech veterans focused on improving safety and specificity in therapy development.
Noam Solomon Immunai

Immunai strikes $85M deal with AstraZeneca to develop new IBD drug target

16.10.25|CTech
AI biotech expands partnership after uncovering novel immune target with its machine learning platform.
מימין מושיק כהן קוטנר נדב בחנוף חברת אומניקס מדיקל

Omnix Medical raises $25 million Series C to tackle drug-resistant infections

15.10.25|CTech
Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.
רוש ROCHE

Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio

18.09.25|CTech
Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.
טליה כהן סולל ו דפנה לייפנפלד

Israeli startup NeuroKaire launches world’s first blood test to personalize depression treatment

09.09.25|Maayan Cohen Rozen
BrightKaire uses AI and stem-cell technology to match patients with effective medications, potentially ending years of trial-and-error prescribing.
בדיקת דם מעבדה פתולוגית Pathology laboratory

Israeli biotech Senseera raises $7.1 million Seed round for liquid biopsy platform

07.01.25|CTech
The GEM BIOMARKERS technology aims to revolutionize diagnostics in oncology, immunology, and liver disease management. 
Converge Bio founders

Converge Bio raises $5.5M in Seed funding to speed up drug discovery and development with GenAI

20.11.24|CTech
The Israeli startup's platform uses large language models (LLMs) trained on biological and chemical data (DNA, RNA, protein sequences, and small molecules) to help biotech and pharmaceutical companies discover and develop better-performing drugs in less time.
Noam Solomon Immunai

Immunai and Teva launch multi-tear AI collaboration for smarter drug development

14.11.24|CTech
The partnership will utilize Immunai’s cutting-edge immune system mapping tools to enhance precision in immunology and oncology trials.  
Enzymit team

Enzymit raises $10 million Series A for cell-free bio-production technology

25.09.24|CTech
The Israeli startup is building a cell-free production platform that aims to make bioproduction faster, simpler, cost-effective, and scalable. 
MNDL Bio Team

Israel’s MNDL Bio is taking on a $116 billion market

08.09.24|CTech
The company has raised a total of $2 million for its AI-powered gene optimization platform
BioGenCell

BioGenCell pioneers revolutionary cell therapy for microvascular disease

11.07.24|Ariela Karmel
CEO Yael Porat spoke to CTech about the Israeli biotech company’s groundbreaking cell therapy technology for the common and debilitating disease whose primary treatment today is amputation 
מייסדי Nucleai

Spatial AI biomarker startup Nucleai raises $14 million led by Merck’s VC arm

03.04.24|CTech
Leveraging AI and machine learning, Nucleai analyzes pathology images and spatial data at the cellular and tissue levels. The proprietary technology extracts detailed patterns and features from medical images, offering insights into the tumor microenvironment, cellular morphology, and spatial relationships between different cell types
More Articles